Methods of identifying agents that selectively activate p38 and/or NKkB signaling
US8268635B2 · kind B2 · utility
9Cited by
4References
3Claims
0Family size
Inventors
Key dates
| Filing date | May 18, 2007 |
| Grant date | Sep 18, 2012 |
| Priority date | — |
| Expiry date | May 18, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of selectively modulating a signalling pathway of interest controlled by a cell receptor involved in signalling through multiple pathways. The method includes exposing the receptor to an agent that modulates signalling by the receptor through the signalling pathway of interest and does not substantially modulate signalling through one or more other signalling pathways controlled by the receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.